A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

Funding supports the distribution of Artera’s flagship test in prostate cancer, as well as further test development across cancers SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal ...

This large-scale, high-quality trial compares a promising alternative screening test to PSA. This may be the breakthrough for prostate cancer screening that we have all been waiting for,” said Kevin C ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...

A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

Jeremy Clarkson has announced that he has been diagnosed with prostate cancer – and others are also opening up about their ...